Paper29142002
Toll-like receptor 2 has a prominent but nonessential role in innate immunity to Staphylococcus aureus pneumonia.
Skerrett SJ and 3 others. Physiol Rep, 2017. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Toll-like receptor 2 has a prominent but nonessential role in innate immunity to Staphylococcus aureus pneumonia. Papers, record 29142002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29142002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Toll-like receptor 2 has a prominent but nonessential role in innate immunity to Staphylococcus aureus pneumonia.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pneumonia, Staphylococcal | Major topic |
| Staphylococcus aureus | Major topic |
| Toll-Like Receptor 2 | Major topic |
| Animals | |
| Antimicrobial Cationic Peptides | |
| Bacterial Load | |
| Bronchoalveolar Lavage Fluid | |
| Colony Count, Microbial | |
| Cytokines | |
| Female | |
| Immunity, Innate | |
| Lung | |
| Macrophages, Alveolar | |
| Male | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Phagocytosis | |
| Cathelicidins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P50 HL073996 | NHLBI NIH HHS | United States | P50HL073996 | PubMed and NIH |
Source NIH RePORTER
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16920954 | Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. | J Immunol | 2006 | https://conductscience.org/library/papers/16920954 | PubMed |
| 2 | 19801452 | Role of Toll-like receptor 5 in the innate immune response to acute P. aeruginosa pneumonia. | Am J Physiol Lung Cell Mol Physiol | 2009 | https://conductscience.org/library/papers/19801452 | PubMed |
| 3 | 16926427 | Staphylococcus aureus-induced corneal inflammation is dependent on Toll-like receptor 2 and myeloid differentiation factor 88. | Infect Immun | 2006 | https://conductscience.org/library/papers/16926427 | PubMed |
| 4 | 15004134 | Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. | J Immunol | 2004 | https://conductscience.org/library/papers/15004134 | PubMed |
| 5 | 26248337 | Inability to sustain intraphagolysosomal killing of Staphylococcus aureus predisposes to bacterial persistence in macrophages. | Cell Microbiol | 2016 | https://conductscience.org/library/papers/26248337 | PubMed |
| 6 | 23558974 | Principles for valid histopathologic scoring in research. | Vet Pathol | 2013 | https://conductscience.org/library/papers/23558974 | PubMed |
| 7 | 17404273 | TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. | J Immunol | 2007 | https://conductscience.org/library/papers/17404273 | PubMed |
| 8 | 18292574 | Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. | J Immunol | 2008 | https://conductscience.org/library/papers/18292574 | PubMed |
| 9 | 18403723 | Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. | Am J Respir Crit Care Med | 2008 | https://conductscience.org/library/papers/18403723 | PubMed |
| 10 | 23166614 | Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen species. | PLoS One | 2012 | https://conductscience.org/library/papers/23166614 | PubMed |
| 11 | 24887410 | Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo. | PLoS One | 2014 | https://conductscience.org/library/papers/24887410 | PubMed |
| 12 | 17312161 | Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. | J Immunol | 2007 | https://conductscience.org/library/papers/17312161 | PubMed |
| 13 | 15359270 | Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. | EMBO Rep | 2004 | https://conductscience.org/library/papers/15359270 | PubMed |
| 14 | 17114491 | The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. | J Immunol | 2006 | https://conductscience.org/library/papers/17114491 | PubMed |
| 15 | 18852243 | Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia. | Infect Immun | 2008 | https://conductscience.org/library/papers/18852243 | PubMed |
| 16 | 10559223 | Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10559223 | PubMed |
| 17 | 10548109 | The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. | Nature | 1999 | https://conductscience.org/library/papers/10548109 | PubMed |
| 18 | 16413925 | MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. | Immunity | 2006 | https://conductscience.org/library/papers/16413925 | PubMed |
| 19 | 25678692 | In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal Endophthalmitis. | Invest Ophthalmol Vis Sci | 2015 | https://conductscience.org/library/papers/25678692 | PubMed |
| 20 | 11934727 | Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. | Am J Respir Crit Care Med | 2002 | https://conductscience.org/library/papers/11934727 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42865970 | Toward precision host-directed immunomodulation in community-acquired pneumonia: a proposed endotype-target-natural-product framework and a roadmap for validation in human lung organoids. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42865970 | PubMed |
| 41766850 | The role of soluble toll-like receptor-2 and 4 in children with pneumonia: a combined analysis of saliva and serum samples. | Front Immunol | 2026 | https://conductscience.org/library/papers/41766850 | PubMed |
| 36226943 | Context-Dependent Roles for Toll-Like Receptors 2 and 9 in the Pathogenesis of Staphylococcus aureus Osteomyelitis. | Infect Immun | 2022 | https://conductscience.org/library/papers/36226943 | PubMed |
| 34899759 | Immunometabolites Drive Bacterial Adaptation to the Airway. | Front Immunol | 2021 | https://conductscience.org/library/papers/34899759 | PubMed |
| 34603755 | Associations of Toll-like Receptor Gene Polymorphisms with NETosis Activity as Prognostic Criteria for the Severity of Pneumonia. | Sovrem Tekhnologii Med | 2021 | https://conductscience.org/library/papers/34603755 | PubMed |
| 33553427 | The Role of Innate Immunity in Pulmonary Infections. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/33553427 | PubMed |
| 30506048 | Exosomes and chronic rhinosinusitis. | World J Otorhinolaryngol Head Neck Surg | 2018 | https://conductscience.org/library/papers/30506048 | PubMed |
| 29142002 | Toll-like receptor 2 has a prominent but nonessential role in innate immunity to Staphylococcus aureus pneumonia. | Physiol Rep | 2017 | https://conductscience.org/library/papers/29142002 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAMP | 820 | PubTator's text mining | https://conductscience.org/library/genes/820 | NCBI Gene |
| CCL2 | 6347 | PubTator's text mining | https://conductscience.org/library/genes/6347 | NCBI Gene |
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| TLR2 | 7097 | PubTator's text mining | https://conductscience.org/library/genes/7097 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29142002
GET https://conductscience.org/api/papers/v1/29142002/references?page=2